Substantial thalamostriatal dopaminergic defect in Unverricht-Lundborg disease

Epilepsia

Volumn 48, Issue 9, 2007, Pages 1768-1773

  Korja, Miikka ^a   Kaasinen, Valtteri ^a,b   Lamusuo, Salla ^c   Parkkola, Riitta ^a   Någren, Kjell ^b   Marttila, Reijo J ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b TURKU PET CENTRE   (Finland)

^c Salo Regional Hospital   (Finland)

Author keywords

Dopamine; Epilepsy; Myoclonus; Positron emission tomography; Unverricht Lundborg disease

Indexed keywords

CLONAZEPAM; DOPAMINE 2 RECEPTOR; ETIRACETAM; PIRACETAM; RACLOPRIDE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CASE REPORT; CEREBELLUM CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DRUG BINDING; DRUG UPTAKE; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THALAMUS;

ADULT; BASAL GANGLIA; BRAIN MAPPING; DOPAMINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION; THALAMUS; UNVERRICHT-LUNDBORG SYNDROME;

EID: 34548400890     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01118.x     Document Type: Article

References (28)

1. Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A 2004) PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology 63 : 73 77.
2. Bouilleret V, Semah F, Biraben A, Taussig D, Chassoux F, Syrota A, Ribeiro MJ 2005) Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis. Journal of Nuclear Medicine 46 : 540 547.
3. Byers TJ, Branton D 1985) Visualization of the protein associations in the erythrocyte membrane skeleton. Proceedings of National Academy of Sciences U S A 82 : 6153 6157.
4. Clinton SM, Haroutunian V, Davis KL, Meador-Woodruff JH 2003) Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. American Journal of Psychiatry 160 : 1100 1109.
5. Di Giaimo R, Riccio M, Santi S, Galeotti C, Ambrosetti DC, Melli M 2002) New insights into the molecular basis of progressive myoclonus epilepsy: a multi-protein complex with cystatin B. Human Molecular Genetics 11 : 2941 2950.
6. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ 1995) Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping 2 : 189 210.
7. Genton P, Michelucci R, Tassinari CA, Roger J 1990) The Ramsay Hunt syndrome revisited: Mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged-red fibers and Baltic myoclonus. Acta Neurologica Scandinavica 81 : 8 15.
8. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ 1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6 : 279 287.
9. Hill MP, Bezard E, McGuire SG, Crossman AR, Brotchie JM, Michel A, Grimee R, Klitgaard H 2003) Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset. Movement Disorders 18 : 1301 1305.
10. Hirvonen J, Aalto S, Lumme V, Nagren K, Kajander J, Vilkman H, Hagelberg N, Oikonen V, Hietala J 2003) Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride. Nuclear Medicine Community 24 : 1207 1214.
11. Kaasinen V, Aalto S, Nagren K, Rinne JO 2004) Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15 : 281 285.
12. Kinrions P, Ibrahim N, Murphy K, Lehesjoki AE, Jarvela I, Delanty N 2003) Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy. Neurology 60 : 1394.
13. Klawans HL, Goetz C, Bergen D 1975) Levodopa-induced myoclonus. Archives of Neurology 32 : 330 334.
14. Koskiniemi M, Donner M, Majuri H, Haltia M, Norio R 1974) Progressive myoclonus epilepsy: a clinical and histopathologic study. Acta Neurologica Scandinavica 50 : 307 332.
15. Kyllerman M, Sommerfelt TK, Hedstrom A, Wennergren G, Holmgren D 1991) Clinical and neurophysiological development of Unverricht-Lundborg disease in four Swedish siblings. Epilepsia 32 : 900 909.
16. Lammertsma AA, Hume SP 1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4 : 153 158.
17. Lehesjoki AE, Koskiniemi M, Sistonen P, Miao J, Hastbacka J, Norio R, de la Chapelle A 1991) Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proceedings of National Academy of Sciences U S A 88 : 3696 3699.
18. Leino E. (1981) Open trial with levodopa-carbidopa combination to patients with long-standing progressive myoclonus epilepsy. Acta Neurologica Scandinavica 63 : 389 394.
19. Leino E, MacDonald E, Airaksinen MM, Riekkinen PJ 1980) Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy. Acta Neurologica Scandinavica 62 : 41 54.
20. Liu SC, Derick LH, Palek J 1987) Visualization of the hexagonal lattice in the erythrocyte membrane skeleton. Journal of Cell Biology 104 : 527 536.
21. Magaudda A, Gelisse P, Genton P 2004) Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 45 : 678 681.
22. Mervaala E, Andermann F, Quesney LF, Krelina M 1990) Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies. Neurology 40 : 53 56.
23. Minami T, Otsuka M, Ichiya Y, Nomura A, Ueda K 1994) Different patterns of [18F]dopa uptake in siblings with hereditary dentato-rubro-pallido-luysian atrophy. Brain Development 16 : 335 338.
24. Mueller HT, Haroutunian V, Davis KL, Meador-Woodruff JH 2004) Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Brain Research. Molecular Brain Research 121 : 60 69.
25. Norio R, Koskiniemi M 1979) Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finish patients. Clinical Genetics 15 : 382 398.
26. Oo TF, Siman R, Burke RE 2002) Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. Experimental Neurology 175 : 1 9.
27. Panzica F, Canafoglia L, Franceschetti S, Binelli S, Ciano C, Visani E, Avanzini G 2003) Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models. Clinical Neurophysiology 114 : 1041 1052.
28. Pennacchio LA, Lehesjoki AE, Stone NE, Willour VL, Virtaneva K, Miao J, D'Amato E, Ramirez L, Faham M, Koskiniemi M, Warrington JA, Norio R, de la Chapelle A, Cox DR, Myers RM 1996) Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271 : 1731 1734.